www.fdanews.com/articles/108307-angiotech-spinning-off-non-taxus-assets
Angiotech Spinning Off Non-Taxus Assets
July 7, 2008
Angiotech Pharmaceuticals is packaging its assets not related to the Taxus coronary stent used in cardiac operations into a new subsidiary, Angiotech Pharmaceutical Interventions.
The Canadian Press
The Canadian Press